The Disease Forecasting Company.

Airfinity tracks, predicts and simulates population level disease outcomes in real time to inform decisions that can increase the global life span.

The world’s most trusted independent health intelligence, cited over 16,000 times in 2022

Analysis & Insights

Airfinity Named The Financial Times' Healthcare Tech Champion 2023
Airfinity Named The Financial Times' Healthcare Tech Champion 2023

Airfinity has been selected as the winning company in the healthcare category of the FT’s 2023 Tech Champions. The awards recognise the tech companies that have risen to the challenges and opportunities presented by new global risks, economic headwinds, geopolitical crises, and disruptive AI.

Read More →

More from Airfinity

Airfinity named among Bloomberg’s UK Startups to Watch 2023

Airfinity appoints first Chief Medical Officer as part of increased pre-emptive health investments

France faces massive increase in dengue cases by 2030

Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death

Climate change and vector-borne disease outbreaks: what you need to know

Elderly RSV vaccines to generate $10.5B annually by 2030 in G7 countries

View All →

In the News

China Warns of Respiratory Illnesses After Pneumonia Hit Kids

Bloomberg | Nov 27, 2023

Gaza races to disinfect refugee shelters as disease starts to spread

The Telegraph | Nov 21, 2023

Airfinity wins Deloitte Fast 50 Rising Star 2023

Deloitte | Nov 16, 2023

Airfinity gives decision makers big picture on health

Financial Times | Nov 15, 2023

View All →

A pioneer in predictive health intelligence


What's happening in a given disease area?

Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.


Identify the true need for a vaccine or a treatment.

Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.


Maximise impact to save lives

Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.

Analyse, simulate, and predict the changing health landscape

Airfinity develops and deploys dynamic disease forecasting models to support horizon scanning, medical countermeasure impact modelling, clinical trial site optimisation, scenario-based demand intelligence, portfolio optimisation and more.

What our users say?


“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”

Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister

hm government

“Airfinity has been instrumental in our country's COVID response.”

Head of UK Government
Vaccine Task Force


“Vaccine production data from Airfinity has been spot on. In a fast moving pandemic, these forecasts are really important for evidence-based policy making.”

Director General,

the economist

“Airfinity has been critical in furnishing us and the rest of the world with COVID-19 numbers.”

James Fransham, Data Journalist,
The Economist